Nen Pitch Deck: Slide-by-Slide Breakdown

Executive Summary and Mission

Slide 1: Title Slide

The deck opens with a high-resolution image of a child in a hospital setting, establishing the emotional and clinical context immediately. The tagline, "Evidence-based health designed for children's minds to improve their lives," emphasizes the scientific foundation of the product. The branding is soft, using a cloud logo with a smiling face, signaling a child-friendly approach.

Slide 2: The Mission

Slide 2 defines Nen as a Digital Therapeutic (DTx) company. It states the company was founded to help kids with cancer, their families, and healthcare providers (HCPs) with pain management . The slide explicitly links pain management to improved overall wellbeing and clinical outcomes, setting the stage for a medical rather than purely wellness-based pitch.

The Problem and Market Opportunity

Slide 3: Total Addressable Market (TAM)

This slide quantifies the crisis in pediatric oncology. It cites four key statistics: 500,000 kids fighting cancer globally, 50,000 kids currently in hospitals, 46 new diagnoses per day, and the fact that nearly 100% of these children will experience pain. The slide notes that oncology is the first indication Nen will pursue due to the "unmet need and underserved pediatric population." Sources from Lancet Oncology and CureSearch are cited to validate these figures.

Slide 4: The Failure of Traditional Approaches

Nen argues that current pain assessment in pediatric cancer is "poorly addressed." The slide highlights that children under 7 years old struggle to differentiate between more than two or three faces on traditional pain scales. Crucially, it notes that 74% of children prefer a technological platform for pain assessment. This slide identifies the specific friction point: the communication gap between a suffering child and a clinical assessment tool.

Slide 5: The Need for Novel Approaches

This slide shifts the focus to healthcare providers (HCPs). It claims that HCPs find it difficult to evaluate pain in small children because adult-based traditional and digital therapies are applied without appropriate modifications. The core thesis is that the lack of kid-specific digital solutions results in a significant burden of pediatric pain that remains unmanaged.

The Solution and Product

Slide 6: Who We Are

Nen introduces its "novel mission-driven approach" which centers on "pain management through play." The slide mentions the two pillars of their intervention: gamification and Cognitive Behavioral Therapy (CBT). The goal is to modulate pain and improve outcomes through a kid-centric care model.

Slide 7: Pain Management with Nen

This slide provides the first look at the product interface. It shows a smartphone screen with a colorful, animated forest environment and diverse avatars. The slide explains that the gamified approach assesses and treats children while offering continuous feedback. It mentions specific modules: "Dolores" for pain management and "Sara and Tony" for mental health and wellbeing. The use of chemical structures (dopamine and serotonin) next to these names suggests a biological basis for the psychological intervention.

Slide 8: Parents Portal

Recognizing that parents are key stakeholders, Nen includes a dedicated portal. This functionality provides health reporting to HCPs, mindfulness tools, community support, and a clinical trial finder. Data from the child's game journey is sent to the portal so parents can track mood and pain status, allowing them to alert medical teams if the pain worsens.

Business Strategy and Competition

Slide 9: Business Model and Expansion

Nen presents a four-stage roadmap. B2C: A patient support tool for advocacy groups, designed for GDPR/HIPAA compliance. B2B: A digital medicine platform involving research collaborations and enterprise-wide agreements. Rx: A standalone Prescription Digital Therapeutic (PDT) seeking reimbursement through payor systems. Expansion: Moving into other chronic pain indications and broadening the target age range from the initial 2-7 to 8-13 and 14-17.

Slide 10: Competitive Landscape

This slide is titled "Landscape demonstrates no direct competitors to nen." However, the slide itself is functionally empty. It lists categories such as "Patient Support," "Symptom Tracker," and "DTx" across the top, but no company names or logos are populated in the grid. This is a notable omission that leaves the investor to guess who the indirect competitors might be.

Financials and Team

Slide 11: Use of Proceeds

The company is seeking a €3-5M convertible note for seed funding. The primary use is for MVP development and clinical evaluation. The slide features a linear timeline of eight milestones: 1) MVP/Beta testing, 2) Patient Centric Design, 3) Initial research collaboration, 4) Patient Advocacy partnership, 5) First Commercial enterprise deal, 6) Geographic expansion, 7) Reimbursement of DTx, and 8) EXIT. Explicitly stating an "EXIT" as the final milestone is a direct signal to VC investors regarding the intended liquidity event.

Slide 12: The Team

The leadership consists of two primary executives. Francesca Domenech Wuttke, PhD (Founder and CEO): A former Chief Digital Officer and pharmaceutical executive with 25 years of experience, including roles in digital health VC. Xènia Riasol Cercós (COO): An expert in launching DTx across Europe and deploying digital strategy. The slide also includes "Doggos" as Chief Comfort Officers, a common culture-building element in modern decks, though it takes up a significant portion of the slide.

Slide 13: Contact Slide

The final slide repeats the tagline and provides direct email addresses for the CEO and COO, set against a background image of a child using a tablet in a hospital bed.

What Nen Does Well

Nen excels at defining a clear, clinical "why." By focusing on the specific inability of children under 7 to use traditional pain scales, they identify a high-value problem that is easily understood by both clinicians and investors. The transition from a B2C support tool to a reimbursed Rx product shows a sophisticated understanding of the digital health landscape. The founder's background as a Chief Digital Officer in pharma provides significant credibility for navigating the complex regulatory and reimbursement hurdles required for a PDT.

What Is Missing from the Deck

The most glaring omission is the competitive analysis on Slide 10. Leaving a landscape slide blank is a missed opportunity to show how Nen differs from general pediatric apps or adult-focused pain management platforms like Hinge Health or Kaia Health. Furthermore, while the deck mentions "clinical evaluation," it does not provide any preliminary data or pilot results to prove the gamified CBT actually reduces pain scores in their target demographic. Finally, the deck lacks a detailed breakdown of the €3-5M spend; it lists milestones but does not allocate specific amounts to R&D, clinical trials, or headcount.

Founder Lessons: What to Copy

Founders should emulate Nen's use of a phased business model (Slide 9). Many DTx startups fail because they aim for reimbursement on day one; Nen's strategy of starting with B2C advocacy groups to build a user base and clinical evidence before moving to the Rx model is a lower-risk path to market. Additionally, the clear link between the product features (gamified CBT) and the biological outcome (pain modulation) helps bridge the gap between a "game" and a "medical device." The inclusion of a Parents Portal is also a smart move, acknowledging that in pediatric health, the user (the child) and the buyer/decision-maker (the parent/HCP) are different entities.